戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  II receptor blockers--have been shown to be renoprotective.
2 antiproteinuric and, therefore, likely to be renoprotective.
3 nhibit the angiotensin-converting enzyme are renoprotective.
4 d in kidney disease and blockade/knockout is renoprotective.
5 nflammatory pathway with tofacitinib was not renoprotective.
6 tor of progression and that its reduction is renoprotective.
7 ne, but elevated hemoglobins F and A(2) were renoprotective.
8 th diabetes, but it is unknown whether it is renoprotective.
9 eneous nuclear ribonucleoprotein F (hnRNP F) renoprotective action in a type 2 diabetes (T2D) mouse m
10  exerted more effective anti-albuminuric and renoprotective action than eplerenone.
11          We have shown that vitamin D exerts renoprotective actions by transcriptionally suppressing
12        In patients with diabetes, additional renoprotective actions of these substances beyond loweri
13 ur previous studies have demonstrated potent renoprotective activity for 1,25-dihydroxyvitamin D (1,2
14 are a general class of steroids that possess renoprotective activity in glomeruli through their inter
15 p-regulation likely accounts for part of the renoprotective activity of vitamin D.
16                         The lack of a truly 'renoprotective' agent has hampered our efforts in preven
17 ated in patients with diabetes; conventional renoprotective agents did not therapeutically target thi
18 fects on both, whereas for other potentially renoprotective agents, development of heart failure has
19 2 diabetes, intensive glucose control can be renoprotective and albuminuria-lowering treatments can s
20 he possibility of a relationship between its renoprotective and anti-inflammatory activity.
21                         Mechanistically, the renoprotective and antiatherosclerotic effects of DMAG a
22 tory cells, WT CD4(+)CD25(+) cells were more renoprotective and localized to the kidney more efficien
23 d granulocytes seem to obscure the potential renoprotective and positive survival effects of pluripot
24 inediones have recently been suggested to be renoprotective, and to modulate podocyte glucocorticoid-
25 ession: treatment of hypertension and use of renoprotective, anti-hypertensive medication.
26 gy inhibition with 3MA markedly reversed the renoprotective, anti-inflammatory and anti-apoptotic eff
27 -induced nephrotoxicity remains unclear, and renoprotective approaches during cisplatin-based chemoth
28               Most human studies testing the renoprotective benefit of adding an angiotensin receptor
29   In conclusion, these data do not suggest a renoprotective benefit of sulodexide in patients with ty
30 her than surrogate markers might clarify the renoprotective benefits of both agents.
31 erythrocytosis with the cardioprotective and renoprotective benefits of these drugs.
32 strate that angiotensin blockade may provide renoprotective benefits, independent of its BP-lowering
33 ery, which associated with activation of the renoprotective beta-hydroxybutyrate signaling pathway.
34 uggest a mechanism for dynamic regulation of renoprotective BMP7 signaling in the S3 segment of the p
35 emically reduced in vivo to nitric oxide, is renoprotective but this observation is yet to be transla
36 ng peroxisomal fatty acid oxidation (FAO) is renoprotective, but no therapy has emerged to leverage t
37 ry potassium intake (90-120 mmol/day) may be renoprotective, but the effects of increasing dietary po
38 utophagosomes in postischemic kidneys may be renoprotective, but whether this accumulation results fr
39                                Tamoxifen was renoprotective despite having no effect on the sustained
40  used as an intermediate end point to assess renoprotective drug efficacy.
41     Whether or not combining MRAs with other renoprotective drugs such as SGLT2 inhibitors might prov
42 ecent clinical studies showing a significant renoprotective effect in patients.
43 y disease, but the mechanism underlying this renoprotective effect is unknown.
44     Based on the previous demonstration of a renoprotective effect of arginine-glycine-aspartic acid
45                                An additional renoprotective effect of irbesartan, independent of achi
46                                          The renoprotective effect of preconditioned nanofibers assoc
47  meta-analysis to comprehensively assess the renoprotective effect of remote ischemic preconditioning
48 cantly lower in mutant rats, demonstrating a renoprotective effect of the mutation.
49      The lack of a statistically significant renoprotective effect of theophylline may result from in
50  The aim of this study is to investigate the renoprotective effect of xenon on early allograft injury
51                                         This renoprotective effect remained significant but attenuate
52 s indicate that natriuretic peptide exerts a renoprotective effect via inhibiting phosphorylation of
53 a gene profiling analysis indicated that the renoprotective effect was associated with increased vita
54                               To address the renoprotective effect(s) of LPO inhibition, the efficacy
55                                         This renoprotective effect, although not complete, was seen w
56 inhibitors in Tg26 mice revealed an additive renoprotective effect, as suggested by reduction of prot
57 de, a GSK3beta activator, largely offset its renoprotective effect.
58      In conclusion, Cav2.2 inhibition exerts renoprotective effects against the progression of diabet
59 hat C5aR1 signaling in kidney tubules exerts renoprotective effects against toxin-induced AKI by limi
60                                        These renoprotective effects associated with inhibition of TGF
61 on, is a candidate additional drug to elicit renoprotective effects beyond therapy with metformin, ra
62 pheral stem cell numbers failed to exert any renoprotective effects but rather was associated both wi
63 actors (HIF-1alpha and HIF-2alpha)-can exert renoprotective effects by promoting autophagic flux and
64 ling, a natriuretic peptide receptor, exerts renoprotective effects by stimulating natriuresis and re
65 rse these modifications could have potential renoprotective effects for diabetic nephropathy.
66 torvastatin, atorvastatin seems to have more renoprotective effects for the studied chronic kidney di
67              Renal ILC2s are associated with renoprotective effects in AKI.
68  phosphodiesterase type 5 (PDE5) might exert renoprotective effects in DN.
69          EA-230 exerted immunomodulatory and renoprotective effects in preclinical models and was saf
70 nthesis of 20-HETE with HET0016 reversed the renoprotective effects in SS.5(BN) rats.
71                           BT503 demonstrated renoprotective effects in three independent proteinuric
72 ed in the kidney, and their agonists exhibit renoprotective effects in type 2 diabetes.
73 tabolic status and/or obesity, exerts direct renoprotective effects in vivo.
74  the first evidence that 2-OHE exerts direct renoprotective effects in vivo.
75 ype 2 diabetes, and canagliflozin may confer renoprotective effects independently of its glycemic eff
76 ls, but whether these actions translate into renoprotective effects is unknown.
77                                          The renoprotective effects of A717 are independent of any ch
78                                          The renoprotective effects of ACE inhibitors may result, in
79 n vivo by small interfering RNA reversed the renoprotective effects of AG.
80       Few studies have directly compared the renoprotective effects of angiotensin II-receptor blocke
81                              We assessed the renoprotective effects of colchicine or metformin in C57
82        Here, the present study evaluated the renoprotective effects of empagliflozin in a mouse model
83                         We conclude that the renoprotective effects of enalapril, losartan, or combin
84                    This study suggests novel renoprotective effects of ET-A blockers and supports fur
85 kidney inflammation and fibrosis, suggesting renoprotective effects of ferric citrate in the setting
86       This mechanism may explain in part the renoprotective effects of Glp1r agonism in diabetic neph
87                                    Thus, the renoprotective effects of LA in D were not attributable
88                                          The renoprotective effects of LIMM102 were neuromedin U rece
89                              We examined the renoprotective effects of Ly, a novel non-steroidal mine
90                              The comparative renoprotective effects of metformin-GLP-1 RA (glucagon-l
91                                          The renoprotective effects of miR-29a in diabetes-induced lo
92 nt10a expression after ADR accompanied these renoprotective effects of paricalcitol.
93                     Our findings confirm the renoprotective effects of puerarin in an experimental mo
94  inhibition of Nur77 expression mediated the renoprotective effects of retinoic acid.
95  factor-1alpha was critical in mediating the renoprotective effects of S1P(2)R inhibition.
96  distinctive pattern of cardioprotective and renoprotective effects of SGLT2 inhibitors is abolished
97 nuria (Sun-MACRO) trial, which evaluated the renoprotective effects of sulodexide in patients with ty
98 uggests a potential link between HGF and the renoprotective effects of uPAR.
99 ggest that CCR2 inhibition with CCX140-B has renoprotective effects on top of current standard of car
100 owever, how these two drugs possess additive renoprotective effects remains unclear.
101                                  These novel renoprotective effects suggest a role for simvastatin in
102                  This intervention conferred renoprotective effects through restoration of lipid meta
103 onic acid), EPC mobilization was blunted and renoprotective effects were absent.
104                                        These renoprotective effects were accompanied by reduced syste
105                                        These renoprotective effects were not observed with hydralazin
106 ctivated receptor-alpha (PPARalpha) displays renoprotective effects with an unclear mechanism.
107    This study was undertaken to evaluate the renoprotective effects, as well as the optimal timing an
108 (Val) as an angiotensin receptor blocker has renoprotective effects, but the molecular mechanisms res
109 in-II receptor blockers (ARBs) have specific renoprotective effects.
110    Animal studies suggest that vitamin D has renoprotective effects.
111 e from a 6-year clinical trial that assessed renoprotective efficacy of losartan.
112                                          The renoprotective efficacy of the vasopeptidase inhibitor o
113 ht be associated with differences in chronic renoprotective efficacy, additional rats were included i
114  evidence supporting its antiproteinuric and renoprotective efficacy.
115 lly, we induced or inhibited activity of the renoprotective enzyme heme oxygenase (HO) and determined
116 thermore, administration of this complex was renoprotective, evidenced by improved renal function, ma
117  identify renal tubular MIF as an endogenous renoprotective factor in progressive kidney diseases, ra
118 eatment prevented downregulation of Smad7, a renoprotective factor in vivo and in vitro.
119 aling pathways while retaining expression of renoprotective factors.
120 ted decline in levels of Klotho and Smad7, 2 renoprotective factors.
121  human antigen R has been reported to have a renoprotective function in acute kidney injury (AKI) but
122 ey disease models demonstrated a substantial renoprotective function of tRNA-Asp-GTC-3'tDR.
123 nsus within the field that estrogen provides renoprotective function.
124 SGLT2i may benefit HTx recipients, including renoprotective, glycemic, vascular, anti-inflammatory, a
125 cyte influx and, more importantly, amplified renoprotective heme-oxygenase-1 protein and mRNA express
126               In this study, we compared the renoprotective, hemodynamic, and hematologic activities
127  Blockade of the renin-angiotensin system is renoprotective in a variety of chronic nephropathies, bu
128                        In conclusion, PFD is renoprotective in diabetic kidney disease and may exert
129 (A(2A)R) activation was recently shown to be renoprotective in diabetic nephropathy.
130 modulating Fcgamma receptor signaling may be renoprotective in diabetic nephropathy.
131            Angiotensin receptor blockers are renoprotective in hypertensive azotemic patients with ty
132                In contrast, VEGF seems to be renoprotective in nondiabetic renal disease.
133 peptidase-4 (DPP-4), which cleaves GLP-1, is renoprotective in rodent ischemia-reperfusion injury mod
134 s, cardioprotective in rodents and pigs, and renoprotective in rodents.
135            The authors conclude that E(2) is renoprotective in the aging DSS rat by attenuating glome
136        Gdf15 contributes to an early acting, renoprotective injury response, modifying immune cell ac
137 ing PPIF as a potential molecular target for renoprotective intervention.
138 lp further improve the cost-effectiveness of renoprotective interventions is a matter of investigatio
139 potentially facilitate earlier initiation of renoprotective measures.
140      Collectively, our results demonstrate a renoprotective mechanism of ATG via PP2A activation and
141                                         This renoprotective meroterpenoid features a unique core stru
142 The bioflavonoids quercetin and curcumin are renoprotective natural antioxidants.
143 progressive kidney disease, underscoring its renoprotective potential.
144 , contributing to their cardioprotective and renoprotective profiles.
145 al and clinical studies have established the renoprotective properties of renin-angiotensin-aldostero
146                         It was observed that renoprotective properties of Renogrit against cisplatin-
147  during preconditioning was essential to the renoprotective properties of the nanofibers.
148  that the two classes of drugs share similar renoprotective properties.
149  agents with potential immunosuppressive and renoprotective properties.
150  these results suggest that adiponectin is a renoprotective protein after podocyte injury.
151 duced downregulation of BMP7 and Klotho, two renoprotective proteins.
152 e addressed the question as to whether these renoprotective purines are altered in the urine of COVID
153 harmacotherapy targeted to restore levels of renoprotective purines may attenuate the risk of AKI in
154    These findings imply that an imbalance in renoprotective purines may contribute to AKI in COVID-19
155    In contrast, the "upstream" precursors of renoprotective purines, namely 5'-AMP and 5'-GMP, were n
156                  This association suggests a renoprotective rather than a tubulotoxic effect of NEFA.
157                               Persistence of renoprotective responses after acute inducible endotheli
158 ocytochemistry, lending further support to a renoprotective role for OPN.
159    Here we report what we believe is a novel renoprotective role for the inducible costimulator ligan
160 hese data indicate that OPN plays a critical renoprotective role in vivo as an inhibitor of CaOx crys
161                 In conclusion, Corin plays a renoprotective role through pro-ANP processing, and defe
162                   They found that BTLA has a renoprotective role through suppression of local Th1-dri
163 ed that zinc dietary supplementation plays a renoprotective role.
164         We have shown that FXR and TGR5 have renoprotective roles in diabetes- and obesity-related ki
165                      However, the effects of renoprotective strategies on the efficacy of cisplatin c
166 e lack of evidence of benefit of traditional renoprotective strategies, and newer techniques that may
167 nd clinical evidence for rIPC as a potential renoprotective strategy, and discusses the underlying me
168                     N-acetylcysteine is more renoprotective than hydration alone.
169 ota warrant further investigation as a novel renoprotective therapy in diabetic nephropathy.
170 ation might provide a therapeutic option for renoprotective therapy.
171 ed angiopoietin-1 therapy shows promise as a renoprotective tool in the early stages of diabetic kidn
172 During the 15 years of follow-up, the use of renoprotective treatment increased from 56 to 82%, and B
173 nclusion, despite the widespread adoption of renoprotective treatment, patients with type 1 diabetes
174 ne in renal function to target and intensify renoprotective treatment.
175                              AKI induces the renoprotective upregulation of survivin expression in ki
176 nduced cell survival, and S1P1R agonists are renoprotective via direct effects on the tubule cells.

 
Page Top